1314528-85-2

Basic information

• Product Name: 3'-(3-chloro-benzoylamino)-4-[2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid
• Synonyms: 3'-(3-chloro-benzoylamino)-4-[2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid
• CAS NO: 1314528-85-2
• Molecular Weight: 540.062
• Mol File: 1314528-85-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3'-(3-chloro-benzoylamino)-4-[2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-(3-chloro-benzoylamino)-4-[2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid(1314528-85-2)
• EPA Substance Registry System: 3'-(3-chloro-benzoylamino)-4-[2-(4-hydroxy-piperidin-1-yl)-2-oxo-ethyl]-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid(1314528-85-2)

Safety Data

• Hazardous Substances Data: 1314528-85-2(Hazardous Substances Data)

Upstream product

• 1314530-93-2 [3'-(3-chloro-benzoylamino)-5'-cyclopropylcarbamoyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl]-acetic acid ethyl ester 
• 1314530-92-1 (3'-amino-5'-cyclopropylcarbamoyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl)-acetic acid ethyl ester 
• 1314530-91-0 [4-(5-cyclopropylcarbamoyl-3-nitro-pyridin-2-yl)-piperazin-1-yl]-acetic acid ethyl ester 
• 1314530-90-9 4-ethoxycarbonylmethyl-3'-nitro-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-carboxylic acid 
• 7477-10-3 6-chloro-5-nitronicotinic acid 
• 5382-16-1 4-HYDROXYPIPERIDINE 
• 1314530-94-3 [3'-(3-chloro-benzoylamino)-5'-cyclopropylcarbamoyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4-yl]-acetic acid. 
• 59184-90-6 ethyl (piperidin-4-yl)acetate 

Relevant articles and documents

CXCR3 RECEPTOR ANTAGONISTS

The present invention relates to compounds of formula I and pharmaceutically acceptable salts thereof, wherein R1 to R3, A, B, X, and n are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.